---All---
  • ---All---
  • Accession
  • Catalog #

MGRN1 Antibody (N-term) Blocking PeptideSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP7634a 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

MGRN1 Antibody (N-term) Blocking Peptide - Product info

Primary AccessionO60291
Clone Names80917049
Calculated MW60753 Da

MGRN1 Antibody (N-term) Blocking Peptide - Additional info

Gene ID 23295
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP7634a was selected from the N-term region of human MGRN1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Format
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

MGRN1 Antibody (N-term) Blocking Peptide - Protein Information

Name MGRN1
Synonyms KIAA0544, RNF156
Function
E3 ubiquitin-protein ligase. Mediates monoubiquitination at multiple sites of TSG101 in the presence of UBE2D1, but not of UBE2G1, nor UBE2H. Plays a role in the regulation of endosome-to- lysosome trafficking. Impairs MC1R- and MC4R-signaling by competing with GNAS-binding to MCRs and inhibiting agonist-induced cAMP production. Does not inhibit ADRB2-signaling. Does not promote MC1R ubiquitination
Cellular Location
Early endosome. Note=The endosomal localization is dependent on the interaction with TSG101 Isoform 2: Cytoplasm, cytosol. Nucleus. Note=Translocation from the cytosol to the nucleus is seen only in the presence of MC1R and MC4R, but not TBXA2R. Excluded from nucleoli Isoform 4: Cytoplasm, cytosol. Cell membrane

MGRN1 Antibody (N-term) Blocking Peptide - Related products

AP7634a: MGRN1 Antibody (N-term)

AP7634b: MGRN1 Antibody (C-term)

RI13299: MGRN1 predesign siRNA

BP7634a: MGRN1 Antibody (N-term) Blocking Peptide

BP7634b: MGRN1 Antibody (C-term) Blocking Peptide

AT2867a: MGRN1 Antibody (monoclonal) (M07)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Mahogunin (MGRN1) is a C3HC4 RING-containing protein with E3 ubiquitin ligase activity in vitro.

REFERENCES

Chakrabarti,O., Cell 137 (6), 1136-1147 (2009)Kim,B.Y., Mol. Biol. Cell 18 (4), 1129-1142 (2007)